Protopanaxatriol is an aglycone of ginsenosides, which has high medicinal values. Production of protopanaxatriol (PPT) from natural ginseng plants requires artificial deglycosylation procedures of ginsenosides via enzymatic or chemo-physical treatments. Metabolic engineering could be an efficient technology for production of ginsenoside sapogenin. For PPT biosynthesis in P. ginseng, damarenediol-II synthase (PgDDS) and two cytochrome P450 enzymes (CYP716A47 and CYP716A53v2) are essentially required.